3 Undervalued Biotechnology Stocks for Thursday, October 03
Discover the top 3 undervalued Biotechnology stocks for Thursday, October 03 based on AAII’s Stock Grades.Omar Beirat
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration. The company also develops NB1, a NELL-1/DBM fusion device for use in lumbar spinal fusion, as well as spine implants, non-union trauma cases, and osteoporosis applications. It serves spine surgeons and patients with a skeletal bone defect or bone-related condition in their spine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion by local administration, osteoporosis, and trauma applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
Commentary & Analysis
3 Undervalued Medical Equipment, Supplies & Distribution Stocks for Monday, September 02
Discover the top 3 undervalued Medical Equipment, Supplies & Distribution stocks for Monday, September 02 based on AAII’s Stock Grades.Omar Beirat
3 Undervalued Medical Equipment, Supplies & Distribution Stocks for Wednesday, July 31
Discover the top 3 undervalued Medical Equipment, Supplies & Distribution stocks for Wednesday, July 31 based on AAII’s Stock Grades.Omar Beirat
4 Undervalued Medical Equipment, Supplies & Distribution Stocks for Monday, July 01
Discover the top 4 undervalued Medical Equipment, Supplies & Distribution stocks for Monday, July 01 based on AAII’s Stock Grades.Grace Malone
5 Undervalued Medical Equipment, Supplies & Distribution Stocks for Wednesday, May 22
Discover the top 5 undervalued Medical Equipment, Supplies & Distribution stocks for Wednesday, May 22 based on AAII’s Stock Grades.Jenna Brashear
Financial Summary
| Share Statistics | BBLG | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1.5 | $251.9 | 1% |
|
| Shares Out (Mil) | 1.8 | 50.8 | 7% |
|
| Institutional Ownership | 95.0% | 92.0% | 66% |
|
| Float (Mil) | 1.8 | 40.5 | 5% |
|
| Beta | 0.56 | 0.95 | 32% |
|
| Avg Daily Volume (000s) | 28 | 447 | 23% |
|
| Price Change (52-week) |
(67.8%) | 54.2% | 10% |
|
| Growth | BBLG | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 14.0% | na |
|
| Net Income (5yr) | (11.5%) | (9.8%) | 28% |
|
| EPS (5yr) | na | 16.3% | na |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | na | (15.6%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | 1 | 1 | |
| Current EPS | ($0.390) | ($1.170) | ($0.640) | |
| Month Ago EPS | ($0.390) | ($1.930) | ($1.260) | |
| # Rev Up | na | 1 | na | |
| # Rev Down | na | 0 | na | |
| Three Months Ago EPS | ($0.500) | ($1.930) | ($1.620) | |
| Year/Year Chg | (8.7%) | (55.8%) | na | |
| Financials | BBLG | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $39 | na |
|
| Net Income (TTM) (Mil) | ($3) | ($43) | 35% |
|
| EPS (TTM) | ($1.917) | ($1.600) | 15% |
|
| Operating Cash Flow (TTM) (Mil) | ($3) | ($30) | 28% |
|
| Net Cash Flow (TTM) (Mil) | na | $3 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $5 | 0% |
|
| Enterprise Value (Q1) (Mil) | ($2) | $182 | 3% |
|
| Valuation | BBLG | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.33 | 2.60 | 5% |
|
| P/E | na | 18.6 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 0.9 | na |
|
| Ratios | BBLG | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 63.8% | na |
|
| Net Margin | na | (64.7%) | na |
|
| ROA | (70.2%) | (49.7%) | 8% |
|
| ROE | (75.4%) | (55.4%) | 12% |
|
| Liabilities to Assets | 6.2% | 30.3% | 3% |
|
| F-Score | 3 | 3 | 19% |
|
Bone Biologics Corporation did not pass any screens on 7/30/2026.
